Hong Kong Stocks Movement | CRO Concept Stocks Under Pressure: PHARMARON (03759) Drops Over 4%, JOINN (06127) Falls Over 3%

Stock News2025-12-22

CRO concept stocks faced downward pressure in Hong Kong trading. As of press time, PHARMARON (03759) declined 4.32% to HK$21.24, while JOINN (06127) fell 3.29% to HK$21.16. ASYMCHEM (06821) dropped 2.31% to HK$78.15, and VIVA BIOTECH (01873) slid 1.98% to HK$1.98.

The market movement follows the U.S. Senate's passage of the revised Biosecure Act as part of the Fiscal Year 2026 National Defense Authorization Act (2026 NDAA) on December 18 (Beijing time). The bill, approved 77-20, has now completed major legislative procedures in both chambers and awaits presidential signing.

Analysts note that while the Biosecure Act has weighed on CRO sector valuations over the past two years, the final version appears more moderate as it doesn't specify targeted companies. With the Federal Reserve entering an interest rate cut cycle and potential improvement in global biopharma financing, the CRO sector may see both earnings recovery and valuation rebound following the bill's enactment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107411470?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-22 15:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107411470","market":"sg","top_or_hot":-1,"title":"Hong Kong Stocks Movement | CRO Concept Stocks Under Pressure: PHARMARON (03759) Drops Over 4%, JOINN (06127) Falls Over 3%","media":"Stock News","content":"<p>CRO concept stocks faced downward pressure in Hong Kong trading. As of press time, PHARMARON (03759) declined 4.32% to HK$21.24, while JOINN (06127) fell 3.29% to HK$21.16. ASYMCHEM (06821) dropped 2.31% to HK$78.15, and VIVA BIOTECH (01873) slid 1.98% to HK$1.98.</p>\n<p>The market movement follows the U.S. Senate's passage of the revised Biosecure Act as part of the Fiscal Year 2026 National Defense Authorization Act (2026 NDAA) on December 18 (Beijing time). The bill, approved 77-20, has now completed major legislative procedures in both chambers and awaits presidential signing.</p>\n<p>Analysts note that while the Biosecure Act has weighed on CRO sector valuations over the past two years, the final version appears more moderate as it doesn't specify targeted companies. With the Federal Reserve entering an interest rate cut cycle and potential improvement in global biopharma financing, the CRO sector may see both earnings recovery and valuation rebound following the bill's enactment.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stocks Movement | CRO Concept Stocks Under Pressure: PHARMARON (03759) Drops Over 4%, JOINN (06127) Falls Over 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stocks Movement | CRO Concept Stocks Under Pressure: PHARMARON (03759) Drops Over 4%, JOINN (06127) Falls Over 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-22 15:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CRO concept stocks faced downward pressure in Hong Kong trading. As of press time, PHARMARON (03759) declined 4.32% to HK$21.24, while JOINN (06127) fell 3.29% to HK$21.16. ASYMCHEM (06821) dropped 2.31% to HK$78.15, and VIVA BIOTECH (01873) slid 1.98% to HK$1.98.</p>\n<p>The market movement follows the U.S. Senate's passage of the revised Biosecure Act as part of the Fiscal Year 2026 National Defense Authorization Act (2026 NDAA) on December 18 (Beijing time). The bill, approved 77-20, has now completed major legislative procedures in both chambers and awaits presidential signing.</p>\n<p>Analysts note that while the Biosecure Act has weighed on CRO sector valuations over the past two years, the final version appears more moderate as it doesn't specify targeted companies. With the Federal Reserve entering an interest rate cut cycle and potential improvement in global biopharma financing, the CRO sector may see both earnings recovery and valuation rebound following the bill's enactment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01873","symbol_name":"维亚生物","start_time":0,"source_url":"","article_id":"1107411470","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107411470","pubTimestamp":1766388737,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CRO concept stocks faced downward pressure in Hong Kong trading. As of press time, PHARMARON (03759) declined 4.32% to HK$21.24, while JOINN (06127) fell 3.29% to HK$21.16. ASYMCHEM (06821) dropped...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300759":"康龙化成","603127":"昭衍新药","01873":"维亚生物","03759":"康龙化成","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","06127":"昭衍新药","BK0216":"研究试验","BK1191":"制药","06821":"凯莱英"},"translate_title":"港股动静|CRO概念股承压：康龙化成(03759)跌超4%，JOINN(06127)跌超3%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300759":1,"603127":1,"06821":1,"01873":1,"06127":1,"03759":1},"content_text":"CRO concept stocks faced downward pressure in Hong Kong trading. As of press time, PHARMARON (03759) declined 4.32% to HK$21.24, while JOINN (06127) fell 3.29% to HK$21.16. ASYMCHEM (06821) dropped 2.31% to HK$78.15, and VIVA BIOTECH (01873) slid 1.98% to HK$1.98.\nThe market movement follows the U.S. Senate's passage of the revised Biosecure Act as part of the Fiscal Year 2026 National Defense Authorization Act (2026 NDAA) on December 18 (Beijing time). The bill, approved 77-20, has now completed major legislative procedures in both chambers and awaits presidential signing.\nAnalysts note that while the Biosecure Act has weighed on CRO sector valuations over the past two years, the final version appears more moderate as it doesn't specify targeted companies. With the Federal Reserve entering an interest rate cut cycle and potential improvement in global biopharma financing, the CRO sector may see both earnings recovery and valuation rebound following the bill's enactment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107411470","isCrawlerRequest":true}